Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Prof. Amotz Agnon reflects on the inevitability of an Israeli earthquake and how to minimize the dangers.
Teva tumbled as its bid was rejected by Mylan while Perrigo rose.
Joint custody is now the default option and child support is calculated accordingly.
As most analysts had predicted, the Bank of Israel has kept the interest rate for May unchanged.
Further analysis of the Phase II/III research data support development of the drug.
A selection of recent deals in the residential real estate market.
US studies showing a connection between energy exploration and small earthquakes could lead to tighter regulation.
London-based, Ukrainian-born Blavatnik has major Israeli holdings including Clal Industries, GetTaxi and ironSource.
Former president of Israel Shimon Peres will provide consulting services to Teva for $10,000 monthly.
A liter of 95-octane gasoline at self-service pumps in Israel is likely to rise to NIS 6.62 in May.
CEO Excellence Nessuah
Frost & Sullivan selects 10 Israeli aerospace, defense and security companies developing promising technologies.
Aerospace & defense
If the acquisition of Mylan does not go through, Teva stands to lose its leading position in the generic sector to Sandoz.
More than thirty suspects, among them lawyers, have been detained for questioning.
Moshe Kahlon's opposition to hobbling the Supreme Court is just a taste of things to come for Netanyahu and the Likud.
FIMI is paying NIS 347 million for 65% of Israeli thermoplastic compounds company Polyram.
Mergers & acquisitions
Senior banking source: Playing with demand only creates a frenzy, which pushes up home prices. The solution is supply.
The US biotech company currently markets its products in Israel through NewPharm.
The funds will be used for a wind energy project in northeast Poland.
Merrill Lynch sees the Bank of Israel cutting the interest rate to zero in tomorrow's announcement for May.